Gossamer Operating Income from 2010 to 2024

GOSS Stock

USD 0.70 0.03 4.11%

Gossamer Bio Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income will likely drop to about -192.9 M in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Gossamer Bio generates from its operations. View All Fundamentals

Operating Income

First Reported

2017-12-31

Previous Quarter

52.1 M

Current Value

-33.9 M

Quarterly Volatility

22.2 M

Covid

Check Gossamer Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gossamer Bio's main balance sheet or income statement drivers, such as Interest Income of 1.5 M, Interest Expense of 8.2 M or Selling General Administrative of 36.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.33. Gossamer financial statements analysis is a perfect complement when working with Gossamer Bio Valuation or Volatility modules.

Check out the analysis of Gossamer Bio Correlation against competitors.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

Latest Gossamer Bio's Operating Income Growth Pattern

Below is the plot of the Operating Income of Gossamer Bio over the last few years. Operating Income is the amount of profit realized from Gossamer Bio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Gossamer Bio is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Gossamer Bio's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gossamer Bio's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Gossamer Operating Income Regression Statistics

	Arithmetic Mean	(92,516,730)
	Coefficient Of Variation	(111.41)
	Mean Deviation	97,719,979
	Median	(6,653,000)
	Standard Deviation	103,069,799
	Sample Variance	10623.4T
	Range	233.9M
	R-Value	(0.87)
	Mean Square Error	2728.1T
	R-Squared	0.76
	Significance	0.000022
	Slope	(20,112,417)
	Total Sum of Squares	148727.4T

Gossamer Operating Income History

	2024	-192.9 M
	2023	-183.8 M
	2022	-218.6 M
	2021	-216.1 M
	2020	-234 M
	2019	-186.1 M
	2018	-149 M

Other Fundumenentals of Gossamer Bio

Non Operating Income Net Other

Gossamer Bio Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Total Liab	Total Current Assets	Capital Surpluse	Net Invested Capital	Net Working Capital	Net Receivables	Deferred Long Term Liab	Capital Stock	Common Stock	Property Plant Equipment	Short Term Debt	Short Long Term Debt
Total Assets		-0.6	0.69	-0.27	-0.72	0.83	0.77	0.91	0.76	1.0	0.85	0.88	1.0	-0.03	-0.28	0.58	0.58	0.58	0.39	-0.28
Total Stockholder Equity	-0.6		-0.44	0.21	0.46	-0.36	-0.67	-0.51	-0.52	-0.6	-0.64	-0.58	-0.57	0.16	-0.27	-0.08	-0.08	-0.27	-0.31	-0.27
Net Tangible Assets	0.69	-0.44		-0.53	-0.21	0.46	0.31	0.38	0.06	0.69	0.5	0.83	0.69	0.41	0.1	0.14	0.14	0.79	-0.08	0.1
Net Debt	-0.27	0.21	-0.53		-0.43	-0.23	0.19	0.06	0.01	-0.26	0.16	-0.16	-0.28	-0.3	-0.61	0.54	0.54	-0.25	0.61	-0.61
Retained Earnings	-0.72	0.46	-0.21	-0.43		-0.7	-0.93	-0.86	-0.73	-0.72	-0.92	-0.71	-0.71	0.45	0.66	-0.91	-0.91	-0.18	-0.84	0.66
Accounts Payable	0.83	-0.36	0.46	-0.23	-0.7		0.8	0.75	0.72	0.84	0.77	0.75	0.83	-0.43	-0.36	0.63	0.63	0.13	0.44	-0.36
Long Term Debt	0.77	-0.67	0.31	0.19	-0.93	0.8		0.81	0.76	0.77	0.95	0.76	0.74	-0.54	-0.38	0.73	0.73	0.1	0.76	-0.38
Long Term Debt Total	0.91	-0.51	0.38	0.06	-0.86	0.75	0.81		0.89	0.91	0.85	0.72	0.91	-0.16	-0.49	0.74	0.74	0.44	0.58	-0.49
Total Liab	0.76	-0.52	0.06	0.01	-0.73	0.72	0.76	0.89		0.76	0.69	0.44	0.74	-0.38	-0.31	0.55	0.55	0.08	0.56	-0.31
Total Current Assets	1.0	-0.6	0.69	-0.26	-0.72	0.84	0.77	0.91	0.76		0.85	0.88	1.0	-0.04	-0.28	0.58	0.58	0.58	0.39	-0.28
Capital Surpluse	0.85	-0.64	0.5	0.16	-0.92	0.77	0.95	0.85	0.69	0.85		0.88	0.82	-0.27	-0.38	0.76	0.76	0.38	0.74	-0.38
Net Invested Capital	0.88	-0.58	0.83	-0.16	-0.71	0.75	0.76	0.72	0.44	0.88	0.88		0.88	-0.03	-0.28	0.6	0.6	0.6	0.41	-0.28
Net Working Capital	1.0	-0.57	0.69	-0.28	-0.71	0.83	0.74	0.91	0.74	1.0	0.82	0.88		-0.03	-0.31	0.59	0.59	0.59	0.36	-0.31
Net Receivables	-0.03	0.16	0.41	-0.3	0.45	-0.43	-0.54	-0.16	-0.38	-0.04	-0.27	-0.03	-0.03		0.34	-0.37	-0.37	0.75	-0.45	0.34
Deferred Long Term Liab	-0.28	-0.27	0.1	-0.61	0.66	-0.36	-0.38	-0.49	-0.31	-0.28	-0.38	-0.28	-0.31	0.34		-0.88	-0.88	-0.03	-0.52	1.0
Capital Stock	0.58	-0.08	0.14	0.54	-0.91	0.63	0.73	0.74	0.55	0.58	0.76	0.6	0.59	-0.37	-0.88		1.0	0.18	0.77	-0.88
Common Stock	0.58	-0.08	0.14	0.54	-0.91	0.63	0.73	0.74	0.55	0.58	0.76	0.6	0.59	-0.37	-0.88	1.0		0.18	0.77	-0.88
Property Plant Equipment	0.58	-0.27	0.79	-0.25	-0.18	0.13	0.1	0.44	0.08	0.58	0.38	0.6	0.59	0.75	-0.03	0.18	0.18		-0.06	-0.03
Short Term Debt	0.39	-0.31	-0.08	0.61	-0.84	0.44	0.76	0.58	0.56	0.39	0.74	0.41	0.36	-0.45	-0.52	0.77	0.77	-0.06		-0.52
Short Long Term Debt	-0.28	-0.27	0.1	-0.61	0.66	-0.36	-0.38	-0.49	-0.31	-0.28	-0.38	-0.28	-0.31	0.34	1.0	-0.88	-0.88	-0.03	-0.52

Click cells to compare fundamentals

About Gossamer Bio Financial Statements

Gossamer Bio shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Gossamer Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Gossamer Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Gossamer Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-183.8 M	-192.9 M
Non Operating Income Net Other	2.8 M	2.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Gossamer Operating Income from 2010 to 2024

Latest Gossamer Bio's Operating Income Growth Pattern

Gossamer Operating Income Regression Statistics

Gossamer Operating Income History

Other Fundumenentals of Gossamer Bio

Gossamer Bio Operating Income component correlations

About Gossamer Bio Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Gossamer Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY